Recro Pharma Reports Third Quarter 2017 Financial Results
Nov 09, 2017 12:00 pm UTC| Business
NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN, Pa., Nov. 09, 2017 ...
Nov 09, 2017 12:00 pm UTC| Business
Charlotte, N.C., Nov. 09, 2017 -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE® bulk acoustic wave (BAW) high-band RF filters for mobile and...
Nabriva Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
Nov 09, 2017 12:00 pm UTC| Business
- Positive topline results from pivotal LEAP 1 trial announced in September, with read-out from second Phase 3 trial, LEAP 2, expected in the spring of 2018 - - $112.7 million cash and investments as of September 30,...
Nov 09, 2017 12:00 pm UTC| Business
HOUSTON, Nov. 09, 2017 -- Synthesis Energy Systems, Inc. (SES) (NASDAQ:SYMX) and Warsaw-based EnCoal Gasification Ltd., a wholly owned subsidiary of EnInvestments sp. z o.o., have formed the joint venture partnership...
AAON Senior Vice President of Administration and Treasurer Kathy I. Sheffield to Retire
Nov 09, 2017 12:00 pm UTC| Business
TULSA, Okla., Nov. 09, 2017 -- AAON, Inc. (NASDAQ:AAON). On November 6, 2017, Kathy I. Sheffield notified AAON, Inc. (the “Company”) of her intent to retire as Senior Vice President, Administration and Treasurer after...
Codexis to Present at Two Investment Conferences in November
Nov 09, 2017 12:00 pm UTC| Business
REDWOOD CITY, Calif., Nov. 09, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November: 8th Annual Craig-Hallum...
ContraFect Announces Third Quarter 2017 Financial Results
Nov 09, 2017 12:00 pm UTC| Business
YONKERS, N.Y., Nov. 09, 2017 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update